Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
American Journal of Physiology. Lung Cellular and Molecular Physiology|December 16, 2025
Bleomycin-induced lung fibrosis and dysfunction is exacerbated by G6PD deficiencyChristina Signoretti, Samuel Fatehi, Rhonda Drewes, et al.British Journal of Pharmacology|May 5, 2026
VEGFR-2 blocker induces pulmonary vascular disease in rats with CRISPR-edited human non-deficient G6PD polymorphism: role of 3D genomic modifications and DNA methylationChristina Signoretti, Shun Matsumura, Jaser Doja, et al.The Journal of Biological Chemistry|May 28, 2026
Glucose-6-phosphate dehydrogenase variants modify 3D genomic organization to suppress maladaptive gene expression and vascular diseaseChristina Signoretti, Shun Matsumura, Melinee D'silva, et al.Journal of the American Heart Association|September 18, 2024
G6pd Variant Increases the Risk of Developing VEGFR (Vascular Endothelial Growth Factor Receptor) Blocker-Induced Pulmonary Vascular DiseaseChristina Signoretti, Shun Matsumura, Samuel Fatehi, et al.The Journal of Biological Chemistry|June 14, 2024
Loss-of-function G6PD variant moderated high-fat diet-induced obesity, adipocyte hypertrophy, and fatty liver in male ratsShun Matsumura, Christina Signoretti, Samuel Fatehi, et al.Pageof 1